Cargando…

Development of oral candidiasis following initiation and rechallenge of extended-release bupropion in a geriatric patient

OBJECTIVE: To report a case of oral candidiasis that developed in a 70-year-old white female both upon initiation and rechallenge of extended-release bupropion therapy. CASE SUMMARY: A 70-year-old female with a past medical history of osteoarthritis, degenerative joint disease, and polycythemia vera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vadiei, Nina, Smith, Tawny L., Garcia-Pittman, Erica C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2018
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063460/ https://www.ncbi.nlm.nih.gov/pubmed/30155394 http://dx.doi.org/10.9740/mhc.2018.07.188

Ejemplares similares

Lithium rechallenge after renal transplant
por: Beasley, Anna K., et al.
Publicado: (2018)

Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI
por: Izci, Filiz, et al.
Publicado: (2015)

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016)

Naltrexone/Bupropion extended release‐induced weight loss is independent of nausea in subjects without diabetes
por: Hong, K., et al.
Publicado: (2016)

Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT
por: Pasha, Hajar, et al.
Publicado: (2020)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Caixàs, Assumpta, et al.
Publicado: (2014)

Hyponatremia Associated with Bupropion
por: Kim, Chang Seong, et al.
Publicado: (2011)

Hyponatremia after initiation and rechallenge with trimethoprim–sulfamethoxazole in an older adult
por: Huntsberry, Ashley M, et al.
Publicado: (2015)

Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation
por: Singh, Pranav, et al.
Publicado: (2010)

Immunology of oral candidiasis
por: Dineshshankar, Janardhanam, et al.
Publicado: (2014)

Oral candidiasis: An overview
por: Singh, Arun, et al.
Publicado: (2014)

Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Buehler, Anna M
Publicado: (2015)

Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023)

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
por: Cremolini, Chiara, et al.
Publicado: (2023)

Can bupropion unmask psychosis
por: Grover, Sandeep, et al.
Publicado: (2009)

Bupropion-Induced Erythema Multiforme
por: Evrensel, Alper, et al.
Publicado: (2015)

Tardive Dyskinesia Associated with Bupropion
por: Tuman, Taha Can, et al.
Publicado: (2017)

Bupropion-Induced Severe Leukocytosis
por: Jolly, Taranjeet S, et al.
Publicado: (2020)

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
por: Takinami, Masaki, et al.
Publicado: (2020)

Possible Addiction Transference From Cocaine Insufflation to Oral Bupropion in Bipolar Patient
por: Costa, Carolina, et al.
Publicado: (2015)

Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide
por: Silva, Edward, et al.
Publicado: (2020)

Peptic Ulcer Disease Following Use of Bupropion: A Case Report
por: Momayez Sanat, Zahra, et al.
Publicado: (2023)

Current Status in Rechallenge of Immunotherapy
por: Hu, Han, et al.
Publicado: (2023)

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
por: Honkanen, Emma A., et al.
Publicado: (2019)

Initial presentation of tonsillar carcinoma with candidiasis
por: Shih, Cheng-Ping, et al.
Publicado: (2019)

Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
por: Siamidi, Angeliki, et al.
Publicado: (2021)

Bupropion hydrobromide propanol hemisolvate
por: Liu, Min, et al.
Publicado: (2011)

Bupropion-Induced Diplopia in an Iranian Patient
por: Fayyazi Bordbar, Mohammad Reza, et al.
Publicado: (2011)

The Effects of Bupropion on Negative Symptoms in Schizophrenia
por: Yassini, Mojtaba, et al.
Publicado: (2014)

Is There a Potential of Misuse for Venlafaxine and Bupropion?
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Bupropion-Associated Delayed Onset Urticaria
por: Gutierrez, Nikolas, et al.
Publicado: (2021)

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder
por: McCarthy, Brian, et al.
Publicado: (2023)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
por: Dahlberg, Sarah, et al.
Publicado: (2022)

Ciclesonide: Oral candidiasis following off-label use: case report
Publicado: (2021)

Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trial
por: Wharton, Sean, et al.
Publicado: (2021)

Successful capecitabine rechallenge following 5-fluorouracil-induced Takotsubo syndrome
por: Abdelrahman, Mohamed, et al.
Publicado: (2016)

Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
por: Efe, Orhan, et al.
Publicado: (2021)

Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
por: Stapleton, John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ako4ml4ts8cc0la447hq9pmgjf